Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter H Krammer

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
Nature Reviews. Immunology|July 24, 2003
Regulation of IL4 gene expression by T cells and therapeutic perspectivesMin Li-Weber, Peter H Krammer
Cancer Immunology, Immunotherapy : CII|May 13, 2005
Tumor counterattack: fact or fiction?Frederik H Igney, Peter H Krammer
Oncogene|April 13, 2004
Death receptors in chemotherapy and cancerKlaus-Michael Debatin, Peter H Krammer
Nature Reviews. Cancer|May 11, 2002
Death and anti-death: tumour resistance to apoptosisFrederik H Igney, Peter H Krammer
Seminars in Oncology|February 19, 2004
Apoptosis in cancer--implications for therapyHenning Schulze-Bergkamen, Peter H Krammer
Journal of Leukocyte Biology|June 7, 2002
Immune escape of tumors: apoptosis resistance and tumor counterattackFrederik H Igney, Peter H Krammer
Seminars in Immunology|October 18, 2003
Function and regulation of the CD95 (APO-1/Fas) ligand in the immune systemMin Li-Weber, Peter H Krammer
Acta Naturae|June 1, 2012
Life and Death Decisions in the CD95 System: Main Pro-and Anti-Apoptotic ModulatorsInna N Lavrik, Peter H Krammer
International Journal of Cancer|January 25, 2002
Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell linesUte A Sartorius, Peter H Krammer
Frontiers in Immunology|May 9, 2012
Molecular mechanisms of treg-mediated T cell suppressionAngelika Schmidt, Nina Oberle, Peter H Krammer
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Nature Reviews. Immunology|July 24, 2003
Regulation of IL4 gene expression by T cells and therapeutic perspectivesMin Li-Weber, Peter H Krammer
Cancer Immunology, Immunotherapy : CII|May 13, 2005
Tumor counterattack: fact or fiction?Frederik H Igney, Peter H Krammer
Oncogene|April 13, 2004
Death receptors in chemotherapy and cancerKlaus-Michael Debatin, Peter H Krammer
Nature Reviews. Cancer|May 11, 2002
Death and anti-death: tumour resistance to apoptosisFrederik H Igney, Peter H Krammer
Seminars in Oncology|February 19, 2004
Apoptosis in cancer--implications for therapyHenning Schulze-Bergkamen, Peter H Krammer
Journal of Leukocyte Biology|June 7, 2002
Immune escape of tumors: apoptosis resistance and tumor counterattackFrederik H Igney, Peter H Krammer
Seminars in Immunology|October 18, 2003
Function and regulation of the CD95 (APO-1/Fas) ligand in the immune systemMin Li-Weber, Peter H Krammer
Acta Naturae|June 1, 2012
Life and Death Decisions in the CD95 System: Main Pro-and Anti-Apoptotic ModulatorsInna N Lavrik, Peter H Krammer
International Journal of Cancer|January 25, 2002
Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell linesUte A Sartorius, Peter H Krammer
Frontiers in Immunology|May 9, 2012
Molecular mechanisms of treg-mediated T cell suppressionAngelika Schmidt, Nina Oberle, Peter H Krammer
Pageof 17